HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aligning U.S. With EU Cosmetic Definition Could Enable Claims, Reduce FDA Warnings

This article was originally published in The Rose Sheet

Executive Summary

Under the European Cosmetics Regulation, cosmetics by definition can “protect” parts of the body and “keep them in good condition,” which provides latitude for structure/function claims that firms do not have in the U.S. While there is interest, particularly among multinationals, for similar license in the states, the tradeoff could be more burdensome requirements for efficacy and safety substantiation that smaller companies could not support.

Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS019414

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel